je.st
news
Mylan targets Perrigo shareholders in latest generics mega-merger attempt
2015-09-14 23:16:14| Biotech - Topix.net
Mylan has been looking to acquire generics and OTC drugmaker Perrigo since it launched a hostile bid in April . Last week Mylan said in a letter "shareholders will receive $75 per share in cash, and own approximately 40% of the new powerhouse company created by the combination," and today has formalised this offer, which values Perrigo at just over $27bn .
Tags: latest
attempt
targets
shareholders
Category:Biotechnology and Pharmaceuticals